|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2005;130:1227-1228
© 2005 The American Association for Thoracic Surgery
Letters to the Editor |
Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford, United Kingdom
We thank Dr Moran for his interest in our editorial concerning the use of radial arteries (RA) as coronary bypass conduits.
1
His letter invites us to expand on two important points covered in our article:
Concerning the first point, we would agree that despite previous anecdotal recommendations there is no substantial evidence for the use of oral calcium channel antagonists to prevent delayed vasospasm of RA conduits. Certainly, Gaudino and associates
2
randomized 120 patients receiving RA grafts to treatment with oral calcium channel antagonist therapy or not, and showed no difference in ischemic symptoms, scintigraphic evidence of ischemia, or RA angiographic patency at 5 years. This is consistent with the data published by Moran and coworkers.
3
Concerning the second point, Moran and colleagues elegantly demonstrated the improved patency of RA conduits when anastomosed to target vessels with high-grade (>70%) proximal stenoses. This finding was subsequently confirmed in a larger series with a longer interval to angiographic follow-up.
4
Graft patency is influenced not only by the biology and quality of the conduit but also by physical factors such as luminal blood pressure and runoff, which govern luminal blood flow. The concept of competitive flow suggests that graft flow is influenced by native coronary flow. Royse and colleagues
5
have reported that blood flow through composite arterial grafts (left internal thoracic arteryRA T-grafts) fell by 44% on reintroduction of native coronary flow. Shear stress resulting from flow activates endothelial nitric oxide synthase and results in the production of nitric oxide.
6
Intuitively, grafted conduits should fare better in conditions of poor native coronary flow typified by high grade coronary stenoses, as increased conduit blood flow will contribute to improved nitric oxide production.
References
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |